Phaserx

Developing RNA therapeutics for orphan liver cancer and inherited metabolic diseases.

placeSeattle, Washington, United States calendar_todayFounded 2006 groups21 employees language phaserx.com

Registered entities

Innovation

20 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 2,618 times.

YearFilings
20125
20136
20146
201510
20169
20176
20185
20191
20201
20212
20222

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Bank & private debt125%
Coming soon